Temsirolimus and Cisplatin offer new way of treating malignant pleural mesothelioma

Key points: - Temsirolimus gives a new way of treating malignant pleural mesothelioma - Temsirolimus is a kinase inhibitor used to treat advanced renal cell carcinoma (RCC) - The conclusion was published in the Journal of Oncology Reports - Temsirolimus works against mesothelioma cells by blocking the action of a gene pathway called mammalian target of rapamycin (mTOR) - Temsirolimus can also be used to prevent the formation of blood vessels that...
READ MORE - Temsirolimus and Cisplatin offer new way of treating malignant pleural mesothelioma

Pineapples’ Bromelain as a therapeutic agent in malignant peritoneal mesothelioma

Key points to remember:- Pineapples or Bromelain could improve the treatment of Mesothelioma- The statement was concluded by a study in Australia- The study was published by the Journal of AntiCancer Drugs-  The addition of bromelain increased the cytotoxicity of cisplatin significantly in both cell lines- Bromelain have the ability to break down MUC-1 in mesothelioma cells through a chemical decomposition process called hydrolyses.- Bromelain...
READ MORE - Pineapples’ Bromelain as a therapeutic agent in malignant peritoneal mesothelioma

Asons Solicitors: Penelitian terbaru hasilkan uji deteksi kanker Mesothelioma terbaru sejak dini

TackleMesothelioma.Blogspot.com – Penelitian tersebut dikeluarkan oleh Clinical Proteomics Journal pada 8 November 2013 oleh satu tim peneliti internasional yang terdiri dari Fedinando Cerciello dan Bern Wollscheid from Institut Biologi Molekul di Zurich. (1)Tim peneliti tersebut menggunakan teknologi Selected Reaction Monitoring-SRM (Pengawasan Reaksi Pilihan untuk mengungkap tanda-tanda khusus dari protein mesothelioma. Sebagaimana dilaporkan,...
READ MORE - Asons Solicitors: Penelitian terbaru hasilkan uji deteksi kanker Mesothelioma terbaru sejak dini

Subsequent HIPEC Treatment Improves Mesothelioma Survival Says Researchers

If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery.The cytoreduction/HIPEC approach has...
READ MORE - Subsequent HIPEC Treatment Improves Mesothelioma Survival Says Researchers

Percobaan Perawatan terhadap Mesothelioma Cancer Dimulai

Puluhan tahun silam, ilmuan dan praktisi medis telah memahami bahwa menghirup serat asbestos adalah penyebab mesothelioma cancer yang berkembang di dalam dinding dada manusia. Hingga hari ini, para praktisi medis juga terus berusaha menemukan perawatan yang tepat untuk meningkatkan dan memperpanjang harapan hidup pasien penderita kanker mesothelioma. Awal tahun ini, peneliti dari University of Leicester, Inggris mengumumkan bahwa mereka akan segera...
READ MORE - Percobaan Perawatan terhadap Mesothelioma Cancer Dimulai

Operasi Kanker Mesothelioma Diragukan Keampuhannya

Penelitian terbaru yang dilakukan di Italia dan disajikan pada Konferensi Dunia ke-15 mengenai Kanker Paru-paru di Sydney, Australia menunjukkan bahwa operasi mesothelioma – apapun itu jenis operasinya - tidak menawarkan manfaat bagi kelangsungan hidup untuk pasien.Mesothelioma adalah kanker ganas yang langka tapi agresif yang sangat tahan terhadap pengobatan kanker standar. Dua jenis operasi mesothelioma dianggap pilihan untuk penderita kanker...
READ MORE - Operasi Kanker Mesothelioma Diragukan Keampuhannya

About Us

    The tacklemesothelioma.blogspot.com Web Site (the "Site") is an online information service provided by Cordova Management ("tacklemesothelioma.blogspot.com "), subject to your compliance with the terms and conditions set forth below. PLEASE READ THIS DOCUMENT CAREFULLY BEFORE ACCESSING OR USING THE SITE. BY ACCESSING OR USING THE SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH BELOW. IF YOU DO NOT WISH TO BE BOUND BY THESE TERMS AND CONDITIONS, YOU MAY NOT ACCESS...
READ MORE - About Us